Canada Markets open in 8 hrs 11 mins

Globus Medical, Inc. (GMED)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
68.58-2.20 (-3.11%)
At close: 04:00PM EST
68.58 +0.12 (+0.18%)
After hours: 04:08PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.09
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 384.23
52 Week Low 359.37
50-Day Moving Average 370.23
200-Day Moving Average 374.70

Share Statistics

Avg Vol (3 month) 3503.83k
Avg Vol (10 day) 3505.38k
Shares Outstanding 579.03M
Implied Shares Outstanding 6N/A
Float 876.59M
% Held by Insiders 10.85%
% Held by Institutions 169.89%
Shares Short (Dec. 14, 2021) 41.03M
Short Ratio (Dec. 14, 2021) 41.72
Short % of Float (Dec. 14, 2021) 41.31%
Short % of Shares Outstanding (Dec. 14, 2021) 41.01%
Shares Short (prior month Nov. 14, 2021) 4782.15k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin 19.87%
Operating Margin (ttm)24.35%

Management Effectiveness

Return on Assets (ttm)8.30%
Return on Equity (ttm)11.93%

Income Statement

Revenue (ttm)941.53M
Revenue Per Share (ttm)9.41
Quarterly Revenue Growth (yoy)6.30%
Gross Profit (ttm)571.58M
EBITDA 299.22M
Net Income Avi to Common (ttm)187.04M
Diluted EPS (ttm)1.82
Quarterly Earnings Growth (yoy)6.80%

Balance Sheet

Total Cash (mrq)553.2M
Total Cash Per Share (mrq)5.45
Total Debt (mrq)5.42M
Total Debt/Equity (mrq)0.32
Current Ratio (mrq)8.00
Book Value Per Share (mrq)16.93

Cash Flow Statement

Operating Cash Flow (ttm)280.2M
Levered Free Cash Flow (ttm)185.1M